Sonia Skarlatos Public Service Award

About the Award

Named for its inaugural co-recipient and tireless gene therapy advocate, the ASGCT’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations. 

Criteria and Nominations

Both ASGCT members and non-members alike are eligible to receive the award. Nomination letters must be 500 words or fewer and be submitted by one or more ASGCT members. Nominees must be available to give a presentation of their work at the ASGCT Annual Meeting.

Nominate yourself or a colleague through September 16! Send nominations letters to awards@asgct.org.

Recipients

2025
Mercedes Serabian, FDA Center for Biologics Evaluation and Research (CBER)

2024
Pat Furlong, Parent Project Muscular Dystrophy (PPMD)

2023
Anthony Fauci, MD, Former Director of the National Institute of Allergy and Infectious Diseases (NIAID)

2022
P.J. Brooks, PhD, NIH

2021
Larry Corey, MD, Fred Hutchinson Cancer Research Center
Kathleen Neuzil, MD, MPH, FIDSA, University of Maryland School of Medicine

2020
Peter Marks, M.D., Ph.D., Center for Biologics Evaluation and Research (CBER), U.S. FDA

2019
The Muscular Dystrophy Association

2018
Francesca Pasinelli, Ph.D. and Fondazione Telethon

2017
George Stamatoyannopoulos, MD, Dr. Sci, University of Washington's School of Medicine

2016
Katherine P. Ponder, MD, Washington University School of Medicine

2015
Rachel Salzman, DVM, The StopALD Foundation

2014
Barbara Netter and Edward Netter, Alliance for Cancer Gene Therapy

2013
Catherine McKeon, PhD, National Institute of Diabetes and Digestive and Kidney Diseases
Sonia I. Skarlatos, PhD, National Heart, Lung, and Blood Institute